Aclaris Pharmaceuticals Private Limited
About Aclaris Pharmaceuticals Private Limited
Data last updated:
Aclaris Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24304UP2020PTC132448. Its GSTIN is 09AATCA8301Q1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Divanshu Shekhar and Sanjeev Kumar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 1 – Shive Bihar Faridi Nagar, Lucknow, Uttar Pradesh, India – 226015.
Company details
Contact details
Aclaris Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered Address1 – Shive Bihar Faridi Nagar, Lucknow, Uttar Pradesh, India – 226015
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aclaris Pharmaceuticals Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Aclaris Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aclaris Pharmaceuticals Private Limited
Aclaris Pharmaceuticals has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Divanshu Shekhar | Director | 05 Oct 2023 | 3 Years 1 Months | Current |
| Sanjeev Kumar | Director | 15 Mar 2023 | 3 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Aclaris Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aclaris Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Aclaris Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AATCA8301Q1ZW | Uttar Pradesh | Active | 26 Aug 2020 |
To see the full GST registrations and return filing status of Aclaris Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aclaris Pharmaceuticals Private Limited has 7 board changes on record since 2022: 2 appointments and 5 cessations. The latest: Kumar Singh Amit ceased to be Director on 02 Dec 2023.
Frequently asked questions
Aclaris Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 August 2020 (6+ years old) and is registered under CIN U24304UP2020PTC132448.
Aclaris Pharmaceuticals has 2 current directors:
- Divanshu Shekhar - Director
- Sanjeev Kumar - Director
The latest financial statements of Aclaris Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Aclaris Pharmaceuticals is 09AATCA8301Q1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Aclaris Pharmaceuticals is U24304UP2020PTC132448. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aclaris Pharmaceuticals was incorporated on 10 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
Kumar Singh Amit ceased to be Director on 02 Dec 2023. Divanshu Shekhar was appointed as Director on 05 Oct 2023. Kumar Rahul ceased to be Managing Director on 05 Oct 2023. Aclaris Pharmaceuticals has 7 board changes on record in total.
The registered office of Aclaris Pharmaceuticals is at 1 – Shive Bihar Faridi Nagar, Lucknow, Uttar Pradesh, India – 226015.
Aclaris Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Aclaris Pharmaceuticals can be reached at its registered office: 1 – Shive Bihar Faridi Nagar, Lucknow, Uttar Pradesh, India – 226015.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
